Automation-enabled assay development for high throughput screening
SPT Labtech Japan
About this webinar Respective assays range from simple binding analysis to complex phenotypic assays with multiple read-out parameters. In order to understand the molecular mode of action (mMoA) of compounds as early as possible in the drug identification process, Merck also implement mMoA assays, such as competition assays or jump dilution assays into the HTS campaigns.
- Date and time Always open
- Entry fee Free